TITLE

Medication Use before, during, and after Pregnancy among Women with Eating Disorders: A Study from the Norwegian Mother and Child Cohort Study

AUTHOR(S)
Lupattelli, Angela; Spigset, Olav; Torgersen, Leila; Zerwas, Stephanie; Hatle, Marianne; Reichborn-Kjennerud, Ted; Bulik, Cynthia M.; Nordeng, Hedvig
PUB. DATE
July 2015
SOURCE
PLoS ONE;7/22/2015, Vol. 10 Issue 7, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Introduction: Little is known about medication use among women with eating disorders in relation to pregnancy. Aims: To explore patterns of and associations between use of psychotropic, gastrointestinal and analgesic medications and eating disorders in the period before, during and after pregnancy. Method: This study is based on the Norwegian Mother and Child Cohort Study (MoBa). A total of 62,019 women, enrolled at approximately 17 weeks' gestation, had valid data from the Norwegian Medical Birth Registry and completed three MoBa questionnaires. The questionnaires provided diagnostic information on broadly defined anorexia nervosa (AN), bulimia nervosa (BN), binge eating disorder (BED) and recurrent self-induced purging in the absence of binge eating (EDNOS-P), along with self-reported use of medication six months before, during, and 0–6 months after pregnancy. Results: The prevalence of eating disorder subtypes before and/or during pregnancy was: 0.09% AN (n = 54), 0.94% BN (n = 585), 0.10% EDNOS-P (n = 61) and 5.00% BED (n = 3104). The highest over-time prevalence of psychotropic use was within the AN (3.7–22.2%) and EDNOS-P (3.3–9.8%) groups. Compared to controls, BN was directly associated with incident use of psychotropics in pregnancy (adjusted RR: 2.25, 99% CI: 1.17–4.32). Having AN (adjusted RR: 5.11, 99% CI: 1.53–17.01) or EDNOS-P (adjusted RR: 6.77, 99% CI: 1.41–32.53) was directly associated with use of anxiolytics/sedatives postpartum. The estimates of use of analgesics (BED) and laxatives (all eating disorders subtypes) were high at all time periods investigated. Conclusions: Use of psychotropic, gastrointestinal, and analgesic medications is extensive among women with eating disorders in the period around pregnancy. Female patients with eating disorders should receive evidence-based counseling about the risk of medication exposure versus the risk of untreated psychiatric illness during pregnancy and postpartum.
ACCESSION #
108734235

 

Related Articles

  • Trends and Determinants of Prescription Drug Use during Pregnancy and Postpartum in British Columbia, 2002–2011: A Population-Based Cohort Study. Smolina, Kate; Hanley, Gillian E.; Mintzes, Barbara; Oberlander, Tim F.; Morgan, Steve // PLoS ONE;May2015, Vol. 10 Issue 5, p1 

    Purpose: To describe trends, patterns, and determinants of prescription drug use during pregnancy and postpartum. Methods: This is a retrospective, population-based study of all women who gave birth between January 2002 and 31 December 2011 in British Columbia, Canada. Study population...

  • Drug use in pregnancy: Knowledge of drug dispensers and pregnant women in Dar es Salaam, Tanzania. Kamuhabwa, Appolinary; Jalal, Rashida // Indian Journal of Pharmacology;Jun2011, Vol. 43 Issue 3, p345 

    More than 90% of pregnant women take prescription or non-prescription drugs at some time during pregnancy. In general, unless absolutely necessary, drugs should not be used during pregnancy because many of them are harmful to the fetus. Appropriate dispensing is one of the steps for rational...

  • Relation of Parity to Pregnancy Outcome in a Rural Community in Zimbabwe. Majoko, F.; Nyström, L.; Munjanja, S. P.; Mason, E.; Lindmark, G. // African Journal of Reproductive Health;Dec2004, Vol. 8 Issue 3, p198 

    This population-based cohort study was conducted to compare pregnancy complications and outcome among nulliparous, low (1-5) and high (≥ 6) parity women. Women who registered for antenatal care and gave birth in Gutu District, Zimbabwe, between January 1995 and June 1998 were classified...

  • Reliability of triclosan measures in repeated urine samples from Norwegian pregnant women. Bertelsen, Randi J.; Engel, Stephanie M.; Jusko, Todd A.; Calafat, Antonia M.; Hoppin, Jane A.; London, Stephanie J.; Eggesbø, Merete; Aase, Heidi; Zeiner, Pål; Reichborn-Kjennerud, Ted; Knudsen, Gun P.; Guidry, Virginia T.; Longnecker, Matthew P. // Journal of Exposure Science & Environmental Epidemiology;Sep/Oct2014, Vol. 24 Issue 5, p517 

    Triclosan (TCS) is a synthetic antibacterial chemical that is used in personal care products and is measurable in urine. Urinary TCS has been associated with allergy in children in Norway and the United States. A reasonable degree of temporal reliability of TCS urinary concentrations has been...

  • A prospective cohort study of a woman's own gestational age and her fecundability. Wildenschild, C.; Riis, A. H.; Ehrenstein, V.; Hatch, E. E.; Wise, L. A.; Rothman, K. J.; Sørensen, H. T.; Mikkelsen, E. M. // Human Reproduction;Apr2015, Vol. 30 Issue 4, p947 

    STUDY QUESTION: What is the magnitude of the association between a woman's gestational age at her own birth and her fecundability (cycle-specific probability of conception)? SUMMARY ANSWER: We found a 62% decrease in fecundability among women born,34 weeks of gestation relative to women born at...

  • Inflammatory Bowel Disease and Risk of Adverse Pregnancy Outcomes. Boyd, Heather A.; Basit, Saima; Harpsøe, Maria C.; Wohlfahrt, Jan; Jess, Tine // PLoS ONE;Jun2015, Vol. 10 Issue 6, p1 

    Background and Objectives: Existing data on pregnancy complications in inflammatory bowel disease (IBD) are inconsistent. To address these inconsistencies, we investigated potential associations between IBD, IBD-related medication use during pregnancy, and pregnancy loss, pre-eclampsia, preterm...

  • Therapeutic Drug Use in Women With Crohn's Disease and Birth Outcomes: A Danish Nationwide Cohort Study. Nørgård, Bente; Pedersen, Lars; Christensen, Lisbet A.; Sørensen, Henrik T. // American Journal of Gastroenterology;Jul2007, Vol. 102 Issue 7, p1406 

    BACKGROUND: Crohn's disease (CD) is associated with increased risk of adverse birth outcomes. However, existing studies have not taken into account the impact of drug treatment. We examined the impact of drug treatment on birth outcomes—low birth weight (LBW), preterm birth, LBW at term,...

  • Drug Utilization Patterns in Pregnant Women A case study at the Mount Hope Women's Hospital in Trinidad, West Indies. Pereira, L. M. Pinto; Nayak, B. S.; Abdul-Lateef, H.; Matmungal, V.; Mendes, K.; Persad, S.; Ramnath, G.; Bekele, I.; Ramsewak, S. // West Indian Medical Journal;Oct2010, Vol. 59 Issue 5, p561 

    Objective: To explore drug (prescription, over-the-counter and herbal) utilization in pregnant women attending a public sector tertiary healthcare institution. Methods: This was a cross-sectional case study in women attending antenatal clinics at the Mount Hope Women's Hospital. Women (506) who...

  • Individual accumulation of heterogeneous risks explains perinatal inequalities within deprived neighbourhoods. Timmermans, Sarah; Bonsel, Gouke; Steegers-Theunissen, R�gine; Mackenbach, Johan; Steyerberg, Ewout; Raat, Hein; Verbrugh, Henri; Tiemeier, Henning; Hofman, Albert; Birnie, Erwin; Looman, Caspar; Jaddoe, Vincent; Steegers, Eric // European Journal of Epidemiology;Feb2011, Vol. 26 Issue 2, p165 

    Dutch' figures on perinatal mortality and morbidity are poor compared to EU-standards. Considerable within-country differences have been reported too, with decreased perinatal health in deprived urban areas. We investigated associations between perinatal risk factors and adverse perinatal...

Share

Read the Article

Courtesy of NEW JERSEY STATE LIBRARY

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics